A consensus in past studies supports that PPARα controls hormones that regulate adiposity, especially in the liver, such as PPARα-induced fibroblast growth factor 21 (FGF21) [20], a well-established anti-obesity and anti-diabetic hepatokine hormone. The gene discussed is PPARA; the disease is obesity disorder.